New Vactech video explains the science behind PRV-101
Our consortium partner Vactech Oy has released a new educational video introducing PRV-101, an investigational vaccine designed to prevent Coxsackie B virus infections. These infections are being studied as a possible trigger of type 1 diabetes. The video presents the evidence linking these common enteroviruses to type 1 diabetes. It also explains how PRV-101 is […]
New ENT1DEP animation explains how viruses may cause type 1 diabetes
New animation explains the science behind a leading theory on what triggers type 1 diabetes, and the prevention strategies now being tested. ENT1DEP has released a new animation titled “How viruses may cause type 1 diabetes. A hope for prevention.” The animation explains the growing evidence linking common viruses, called enteroviruses, to the onset of […]
ENT1DEP Young Research Network (YRN)
The Young Researchers Network (YRN) is an initiative within the ENT1DEP project that brings together early career researchers from across the consortium, including PhD candidates, postdoctoral researchers, and junior scientists. The network was established to strengthen collaboration across work packages and to provide a dedicated platform where young researchers can present their ongoing research work, […]
ENT1DEP Consortium Meeting in Oslo
Our consortium met in Oslo on 5th-6th November 2025 for two productive days of discussions, updates, and planning across all work packages. It was great to have all the partners from Tempere University (TAU), Oslo University Hospital (OUS), University of Helsinki (UH), Karolinska Institutet (KI), INSERM, University of Tartu (UTARTU), VACTECH, empirica and others institution […]
International Symposium: Exploring Viral Triggers in Autoimmunity
On November 4, 2025, the Oslo Diabetes Research Center and ENT1DEP Study Group hosted an International Symposium title, The Role of Virus in the Etiology of Autoimmune Diseases. The event brought together clinicians, researchers, and experts in virology and immunology to explore how viral infections may contribute to autoimmune diseases. The program examined three key […]
ENT1DEP at EASD 2025: Insights on Viruses and Type 1 Diabetes
In an engaging EASD live interview titled “EASD 2025: Is Type 1 Diabetes a Slow Virus Disease?, our ENT1DEP work package partners and experts, Prof. Knut Dahl-Jørgensen (University of Oslo) and Prof. Heikki A. Hyöty (Tampere University), joined Prof. Decio L. Eizirik (Université Libre de Bruxelles) for a conversation with the EASD TV host Vivienne […]
ENT1DEP @ 17th nPOD Annual Scientific Meeting
Our PI Vikash Chandra from the University of Helsinki is participated in the Key Question Group discussion on “In Vivo and in Vitro Translation Studies to Advance Therapies for T1D” during the 17th Annual Scientific Meeting of the Network for Pancreatic Organ Donors (nPod). This session took place during the 17th Annual Scientific Meeting of […]
Consortium meeting in Sigtuna, Sweden
The first consortium meeting since the kick-off took place from 4th to 5th of March 2025 in Sigtuna, Sweden. Our partners and work packages demonstrated the scientific progress and first results on: In addition, the consortium participated in an exploitation workshop and discussed future dissemination opportunities. Organised by our partners from the Karolinska Institutet, the […]
ENT1DEP at Diabetes UK Professional Conference
Our partner PI, Dr. Roberto Mallone, will represent ENT1DEP at the Diabetes UK Professional Conference Diabetes UK Professional Conference📅 Date: February 26-28, 2025📍 Location: Glasgow, UK🔗 Event Link: https://www.diabetes.org.uk/diabetes-uk-professional-conference Presentation Title: “The ménage à trois between beta cells, T cells, and interferons” Key Highlights: T1D results from an interplay between autoimmune T cells and dysfunctional […]
ENT1DEP @ SANOFI BR1DGE Summit
Our work package partner INSERM‘s PI, Dr. Roberto Mallone, will share key insights into Type 1 Diabetes (T1D) research at the BR1DGE summit. BR1DGE is a global medical education program developed by Sanofi to enhance understanding of presymptomatic T1D. BR1DGE Summit📅 Date: February 17-18, 2025📍 Location: Barcelona, Spain🔗 Event Link (Invitation-only) Presentation Title: “Journey Around […]